Healthcare news and intelligence for Southern Africa
Daily reporting for the pharmaceutical, medical scheme and hospital sectors, published by Health Matters since 1994.
05.11.2026
Rare disease funding is under scrutiny after the KeyHealth ruling. See how schemes could share the cost of treatments such as Ultomiris.
Latest
More news
02.11.2026
Explore the Dis-Chem digital platform and see how it connects prescriptions and shopping in a seamless online experience.
30.10.2026
Western Cape urges national action on medicine shortages and possible port delays affecting public healthcare.
30.10.2026
China clinical trials offer drugmakers lower costs and faster recruitment, but safety and data concerns persist.
28.10.2026
Medical scheme increases in 2027 range from 7.35% to 8.9%. Ageing members, chronic illness and medicine costs drive contributions higher.
28.10.2026
GLP-1 obesity treatment remains unavailable in the public sector as officials delay a review despite WHO guidance. Read about the barriers.
27.10.2026
Aspen Manufacturing to more than double EBITDA in 2027 as sterile operations, insulin and new production lines replace a lost mRNA deal.
27.10.2026
Understand the significance of district health leadership in fostering trust and improving healthcare in South Africa's public facilities.
26.10.2026
Critics say the Gauteng health department should be placed under administration as chronic medicine shortages force patients to split pills.
25.10.2026
Actuaries warn that gap cover and primary healthcare plans are shifting costs and undermining medical scheme efforts to contain spending.
25.10.2026
Clicks' growth strategy targets GLP-1 medicines, oncology, medical consumables, and digital pharmacy to diversify beyond retail stores.
23.10.2026
The High Court set aside R12.6bn in TLD contracts in the ARV tender, ordering Cipla’s inclusion and excluding Viatris and Innovata.
The archive
Browse every Health Matters article by month.